Leadership Overview
Piramal Group has 7 executives leading key functions including strategy, marketing, technology, retail lending, financial oversight, mergers and acquisitions, and group operations.
Driven by a commitment to innovation, Piramal Group delivers advanced financial and pharmaceutical solutions while maintaining a global footprint across diverse industry verticals through AI-driven platforms.
Driven by a commitment to innovation, Piramal Group delivers advanced financial and pharmaceutical solutions while maintaining a global footprint across diverse industry verticals through AI-driven platforms.
Leadership Roles at Piramal Group
Sai Ponugoti - Chief Executive Officer
Sai Ponugoti, the Chief Executive Officer at Piramal Group, directs the overarching strategic vision for the conglomerate. Ponugoti architects long-term growth initiatives across pharmaceuticals, financial services, and real estate sectors. By aligning corporate objectives with market demands, the Chief Executive Officer ensures the organization maintains a competitive edge in global markets. This leadership role involves constant evaluation of portfolio performance and the integration of AI-driven technologies to optimize business outcomes. Sai Ponugoti manages high-level stakeholder relationships and drives the expansion of the company's footprint across international territories. Through rigorous oversight of diverse business units, the Chief Executive Officer fosters a culture of operational excellence and sustainable development. The executive maintains focus on delivering value to shareholders while navigating complex regulatory environments. Ultimately, Ponugoti secures the future trajectory of the enterprise by championing innovation and strategic agility.
Vivek Valsaraj - Chief Financial Officer, Piramal Pharma Limited
Vivek Valsaraj, the Chief Financial Officer, Piramal Pharma Limited at Piramal Group, directs the financial strategy and fiscal health of the pharmaceutical division. Valsaraj architects robust financial planning and analysis frameworks that support research, development, and manufacturing operations. By overseeing capital allocation and cost management, the Chief Financial Officer, Piramal Pharma Limited ensures the division maintains profitability and sustainable growth. This leadership role involves managing complex financial reporting and compliance requirements within the global pharmaceutical industry. Vivek Valsaraj collaborates with the executive team to evaluate investment opportunities and optimize the balance sheet. Through diligent oversight of financial performance, the Chief Financial Officer, Piramal Pharma Limited drives the strategic objectives of the pharmaceutical business. The executive monitors market fluctuations to protect the company's assets and ensure long-term stability. Ultimately, Valsaraj secures the financial resources necessary for the division to innovate and expand its market reach.
Vikas Arora - Chief Operating Officer, Retail Lending
Vikas Arora, the Chief Operating Officer, Retail Lending at Piramal Group, directs the daily operations and service delivery for the retail lending division. Arora architects efficient workflows that streamline loan processing and customer interactions. By overseeing the implementation of AI-driven credit assessment tools, the Chief Operating Officer, Retail Lending ensures rapid and accurate financial solutions for a diverse client base. This leadership role involves managing regional teams to maintain high standards of service quality across the market. Vikas Arora coordinates with the technology department to refine digital platforms, enhancing the overall user experience. Through rigorous performance monitoring, the Chief Operating Officer, Retail Lending drives growth in the retail sector while mitigating operational risks. The executive focuses on scaling lending operations to meet increasing demand in the financial services vertical. Ultimately, Arora ensures the retail lending business remains a cornerstone of the company's financial success.
Viral Gandhi - President & Group Chief Information Officer
Viral Gandhi, the President & Group Chief Information Officer at Piramal Group, directs the digital transformation and technology infrastructure for the entire conglomerate. Gandhi architects scalable AI-driven platforms that support the company's financial and pharmaceutical operations. By overseeing the integration of advanced software solutions, the President & Group Chief Information Officer ensures data security and operational efficiency across all business units. This leadership role involves managing complex IT projects that facilitate retail and wholesale lending activities. Viral Gandhi collaborates with other C-suite leaders to align technological capabilities with the broader corporate mission. Through the implementation of robust digital frameworks, the President & Group Chief Information Officer drives innovation in service delivery. The executive maintains oversight of global technology standards, ensuring the organization remains at the forefront of industry advancements. Ultimately, Gandhi secures the technological foundation necessary for sustained market competitiveness and operational excellence.
Jatin Lal - President, Mergers & Acquisitions
Jatin Lal, the President, Mergers & Acquisitions at Piramal Group, directs the identification and execution of strategic growth opportunities. Lal architects complex transaction structures that expand the company's presence in pharmaceuticals, financial services, and real estate. By overseeing the due diligence process and integration of new assets, the President, Mergers & Acquisitions ensures that all acquisitions align with the long-term corporate vision. This leadership role involves negotiating high-stakes deals and managing relationships with external partners and investment banks. Jatin Lal collaborates with the Board to assess market trends and identify potential targets that enhance the conglomerate's competitive advantage. Through the strategic deployment of capital, the President, Mergers & Acquisitions drives inorganic growth and portfolio diversification. The executive maintains a focus on maximizing shareholder value through disciplined investment strategies. Ultimately, Lal secures the future of the organization by successfully integrating new businesses into the existing operational ecosystem.
Rupen Jhaveri - Group President
Rupen Jhaveri, the Group President at Piramal Group, directs the operational synergy and strategic alignment across the conglomerate's diverse business units. Jhaveri architects cross-functional initiatives that leverage the company's strengths in pharmaceuticals and financial services. By overseeing the execution of key corporate projects, the Group President ensures that all divisions contribute effectively to the overall mission. This leadership role involves coordinating with other C-suite executives to streamline processes and improve organizational efficiency. Rupen Jhaveri monitors the performance of various business verticals, providing guidance to ensure adherence to corporate standards. Through the implementation of best practices, the Group President drives operational excellence and fosters a culture of accountability. The executive focuses on identifying opportunities for collaboration between departments to maximize market impact. Ultimately, Jhaveri secures the cohesion of the enterprise, ensuring that all business activities support the long-term growth and stability of the organization.
Arvind Iyer - Chief Marketing Officer
Arvind Iyer, the Chief Marketing Officer at Piramal Group, manages the brand identity and market positioning for the conglomerate. Iyer architects comprehensive marketing strategies that highlight the company's diverse portfolio in pharmaceuticals and financial services. By leveraging data analytics and consumer insights, the Chief Marketing Officer drives engagement across retail and wholesale lending platforms. This leadership role involves coordinating with cross-functional teams to ensure consistent messaging across global markets. Arvind Iyer oversees the development of digital campaigns that amplify the impact of AI-driven financial solutions. Through strategic brand management, the Chief Marketing Officer strengthens the market presence of the organization. The executive monitors industry trends to adapt communication strategies, ensuring alignment with the evolving needs of varied industry verticals. Ultimately, Iyer enhances the reputation of the company by executing targeted outreach programs that support long-term growth and customer acquisition.
Explore Leadership Teams in Holding Companies & Conglomerates
Headquartered in Chicago, Illinois, Marmon Holdings, Inc. is a global industrial organization comprising 11 diverse business sectors and more than 125 autonomous manufacturing and service businesses.
Company Leadership AP
CS
Elevate ENT offers practice management support that connects ear, nose, and throat (ENT) practices across the nation with the resources and infrastructure they need to break down the barriers that stand in the way of high-quality patient care. We support patients to more effectively and comfortably navigate the healthcare system by connecting them with the top-rated providers of otolaryngology care and the practices we trust most deeply. We remain committed to making your quest for high-quality care as simple and convenient as it should be.
Company Leadership
CH
Neighborly is a company that specializes in buying and building-related businesses that would provide high-quality residential and light commercial services. Neighborly is located in Texas.
Company Leadership
CK
JH
G42 is a leading artificial intelligence and cloud computing technology company founded in 2018 and headquartered in Abu Dhabi, United Arab Emirates. Chaired by Tahnoon bin Zayed Al Nahyan from the UAE ruling family and led by Group CEO Peng Xiao, G42 is a unique technology group with a mission to invent visionary artificial intelligence for a better everyday. The company champions AI as a powerful force for good across industries and societies, operating in over 30 countries worldwide. G42 delivers the full spectrum of AI solutions and services from idea to scale, focusing on AI development in industries including government, healthcare, finance, oil and gas, aviation, hospitality, energy, governance, and security. The company performs AI research and development on computer vision, machine learning, and natural language processing through its subsidiary, the Inception Institute of Artificial Intelligence. G42 has built what it calls the Intelligence Grid, a unified backbone that connects compute, cloud, data centers, connectivity, and domain-specific AI solutions delivered as a super-utility that is reliable, secure, and always accessible. The group comprises ten portfolio companies working toward one shared mission: to build the Intelligence Grid and solve real-world challenges at speed and scale. Key subsidiaries include M42, a tech-enabled healthcare company; Core42, which delivers enterprise and sovereign AI infrastructure; Presight, which combines AI with powerful analytics; Khazna, the largest data center platform in the UAE and Middle East with over 70 percent market share; Space42, a SpaceTech company applying AI beyond Earth; AIQ, a joint venture with ADNOC bringing AI to energy operations; CPX, providing cybersecurity solutions; Astra Tech, simplifying financial connections; and Inception, the core intelligence layer transforming data and compute infrastructure into applied AI solutions. G42 is majority owned by state-owned Mubadala Investment Company, which took a stake in 2020 and transferred ...
Company Leadership AS
RI
FG
Frequently Asked Questions Regarding Piramal Group Top Executives and Leadership Team
